Intrasense (ALINS.PA) Stock Price

Intrasense Price

🇫🇷Euronext·CLOSED
0.23EUR
Market closed
Today +/-
Today %

Intrasense (ALINS.PA) Stock | ISIN FR0011179886 | WKN A1W6V5. The current Intrasense stock price is 0.23 EUR (2026). Revenue is 7.17 B EUR. Net income is -1.63 M EUR. The P/E ratio is -7.35. Market capitalization is 12.02 M EUR. Intrasense operates in the Health sector.

Intrasense stock price

Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Intrasense over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Intrasense stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Intrasense's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Intrasense Stock Price History
DateIntrasense Price
Access this data via the Eulerpool API

Intrasense Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
2.54 M EUR
-2.05 M EUR
-1.62 M EUR
Jan 1, 2012
4.1 M EUR
-1.25 M EUR
-550,000 EUR
Jan 1, 2013
4.15 M EUR
-2.59 M EUR
-1.84 M EUR
Jan 1, 2014
2.41 M EUR
-5.22 M EUR
-5.47 M EUR
Jan 1, 2015
2.89 M EUR
-2.19 M EUR
-2.75 M EUR
Jan 1, 2016
3.02 M EUR
-1.94 M EUR
-1.77 M EUR
Jan 1, 2017
2.22 M EUR
-2.31 M EUR
-2.1 M EUR
Jan 1, 2018
3.06 M EUR
-1.27 M EUR
-1.51 M EUR
Jan 1, 2019
3.32 M EUR
-792,000 EUR
-912,000 EUR
Jan 1, 2020
3.44 M EUR
-626,000 EUR
-704,000 EUR
Jan 1, 2021
4.19 M EUR
-1.17 M EUR
-1.2 M EUR
Jan 1, 2022
3.79 M EUR
-3.38 M EUR
-3.42 M EUR
Jan 1, 2023
3.31 M EUR
-3.52 M EUR
-3.58 M EUR
Jan 1, 2024
2.25 M EUR
-5.62 M EUR
-5.66 M EUR
Invalid Date
5.49 B EUR
-2.75 B EUR
-2.72 M EUR

Intrasense Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 1:59 PM
 
REVENUE (M EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M EUR)
NET INCOME (M EUR)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Intrasense generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Intrasense retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Intrasense's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Intrasense has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Intrasense's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Intrasense stock margins

The Intrasense margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Intrasense. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Intrasense.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
67.32 %
-80.71 %
-63.78 %
Jan 1, 2012
68.54 %
-30.49 %
-13.41 %
Jan 1, 2013
60.48 %
-62.41 %
-44.34 %
Jan 1, 2014
37.76 %
-216.6 %
-226.97 %
Jan 1, 2015
55.71 %
-75.78 %
-95.16 %
Jan 1, 2016
53.92 %
-64.25 %
-58.56 %
Jan 1, 2017
63.63 %
-103.98 %
-94.63 %
Jan 1, 2018
75.23 %
-41.62 %
-49.26 %
Jan 1, 2019
86.56 %
-23.87 %
-27.49 %
Jan 1, 2020
84.34 %
-18.19 %
-20.46 %
Jan 1, 2021
84.52 %
-27.9 %
-28.74 %
Jan 1, 2022
93.54 %
-89.23 %
-90.24 %
Jan 1, 2023
89.08 %
-106.48 %
-108.29 %
Jan 1, 2024
69.46 %
-250.13 %
-251.78 %
Invalid Date
69.46 %
-50.17 %
-0.05 %

Intrasense Stock Revenue, EBIT, Earnings per Share

The Intrasense earnings per share therefore indicates how much revenue Intrasense has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2011
1.18 EUR
-0.95 EUR
-0.75 EUR
Jan 1, 2012
1.31 EUR
-0.4 EUR
-0.18 EUR
Jan 1, 2013
1.33 EUR
-0.83 EUR
-0.59 EUR
Jan 1, 2014
0.57 EUR
-1.24 EUR
-1.3 EUR
Jan 1, 2015
0.46 EUR
-0.35 EUR
-0.44 EUR
Jan 1, 2016
0.28 EUR
-0.18 EUR
-0.16 EUR
Jan 1, 2017
0.18 EUR
-0.19 EUR
-0.17 EUR
Jan 1, 2018
0.16 EUR
-0.07 EUR
-0.08 EUR
Jan 1, 2019
0.16 EUR
-0.04 EUR
-0.04 EUR
Jan 1, 2020
0.15 EUR
-0.03 EUR
-0.03 EUR
Jan 1, 2021
0.15 EUR
-0.04 EUR
-0.04 EUR
Jan 1, 2022
0.12 EUR
-0.11 EUR
-0.11 EUR
Jan 1, 2023
0.06 EUR
-0.07 EUR
-0.07 EUR
Jan 1, 2024
0.04 EUR
-0.11 EUR
-0.11 EUR
Invalid Date
104.06 EUR
-52.44 EUR
-0.05 EUR

Intrasense business model & stock analysis

The company Intrasense SA, headquartered in France, is a leading provider of medical image processing software and solutions. The company was founded in 2004 by a group of engineers and has already established itself as a major player in the industry. Intrasense SA offers a wide range of products and solutions for medical image processing. Their software platform Myrian® allows radiologists and doctors to integrate, visualize, and analyze images and data from multiple sources. The platform also provides advanced tools and algorithms for 3D image processing, allowing doctors to analyze and interpret complex medical images. Intrasense SA's products are tailored to the needs of hospitals, clinics, and research institutions to support better medical diagnosis and therapy. Intrasense SA has several divisions that focus on specific medical areas. One of these divisions is oncology. Intrasense SA offers specialized solutions for the diagnosis and treatment of cancer. Their software can perform advanced cancer measurements and enables radiologists to identify and classify lesions related to different types of cancer. Another division of the company is cardiology. Intrasense SA offers advanced solutions for the diagnosis and treatment of heart diseases. Their software allows for precise and comprehensive analysis of heart function and provides valuable information for the assessment of heart conditions. Intrasense SA also has a division for neuroradiology. This division offers advanced solutions for the diagnosis and treatment of neurological disorders. Intrasense SA's platform allows for precise analysis of brain structure and function and provides important information for the evaluation of brain injuries and diseases. Intrasense SA has experienced significant international expansion in recent years. The company now operates branches in France, the United States, Germany, and Italy, and its products are sold worldwide. The rapid growth of the company can be attributed to the quality of its products and high customer satisfaction. Intrasense SA is committed to continuing to develop and provide innovative solutions for medical image processing areas. Their commitment to quality and customer satisfaction has led the company to enjoy a high reputation in the industry. Overall, Intrasense SA is a dynamic and innovative company that specializes in creating solutions that revolutionize medical image processing. They offer products that meet the clinical needs across various medical specialties, including oncology, cardiology, and neuroradiology. Their ability to develop customer-oriented solutions has made the company a key player in the industry in a short period, and it is expected to continue to play a significant role in the advancement of medical image processing in the future.

Intrasense SWOT Analysis

Strengths

1. Established brand reputation: Intrasense SA has built a strong reputation in the market due to its reliable and innovative product offerings.

2. Advanced technology: The company utilizes cutting-edge technology, allowing them to deliver state-of-the-art medical imaging solutions.

3. Strong customer base: Intrasense SA has established long-term relationships with a wide range of customers, including hospitals, clinics, and healthcare professionals.

Weaknesses

1. Limited market presence: Intrasense SA may face challenges in expanding into new markets due to its current limited geographical reach.

2. Reliance on key customers: The company's revenue heavily relies on a few key customers, making it vulnerable to changes in their purchasing decisions.

3. High research and development costs: Intrasense SA invests a significant amount in R&D, which puts pressure on their financial resources.

Opportunities

1. Emerging markets: Expanding into emerging markets could provide growth opportunities for Intrasense SA, as these markets have a rising demand for advanced medical imaging solutions.

2. Increasing healthcare expenditure: Continuous growth in healthcare spending globally creates opportunities for the company to offer its innovative products to a larger customer base.

3. Strategic partnerships: Collaborating with other healthcare technology companies can allow Intrasense SA to leverage complementary expertise and enter new markets more effectively.

Threats

1. Intense competition: Intrasense SA operates in a highly competitive industry where other companies are also striving to develop advanced medical imaging solutions.

2. Regulatory challenges: Compliance with changing regulations and obtaining necessary certifications can pose challenges for Intrasense SA in certain markets.

3. Economic downturns: Economic fluctuations and recessions can impact the purchasing power of customers and potentially reduce the demand for medical imaging solutions.

Intrasense Eulerpool Fair Value

Intrasense historical P/E ratio, EBIT multiple, and P/S ratio

Intrasense annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Intrasense shares outstanding

The number of shares was Intrasense in 2025 — This indicates how many shares 52.484 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2011
2.15 M base_Shares
Jan 1, 2012
3.12 M base_Shares
Jan 1, 2013
3.13 M base_Shares
Jan 1, 2014
4.22 M base_Shares
Jan 1, 2015
6.22 M base_Shares
Jan 1, 2016
10.72 M base_Shares
Jan 1, 2017
12.37 M base_Shares
Jan 1, 2018
19.55 M base_Shares
Jan 1, 2019
20.5 M base_Shares
Jan 1, 2020
23.66 M base_Shares
Jan 1, 2021
27.91 M base_Shares
Jan 1, 2022
31.33 M base_Shares
Jan 1, 2023
51.33 M base_Shares
Jan 1, 2024
52.48 M base_Shares
Invalid Date
52.48 M base_Shares
Price targets and forecasts for Intrasense are not yet available.

Intrasense shareholder structure

% Name
55.49689%
Guerbet Family
Guerbet Family
1.7728%
Intrasense SAManagement et administrateurs
Intrasense SAManagement et administrateurs
0.89136%
Reymond (Nicolas)
Reymond (Nicolas)
0%
Bamiere (Charlotte)
Bamiere (Charlotte)
0%
Estampes (Jérôme)
Estampes (Jérôme)
0%
Nicolas (Francois)
Nicolas (Francois)
0%
Larpin (Anne)
Larpin (Anne)
0%
Rullier (Patrice)
Rullier (Patrice)
0%
Lesieur (Michele)
Lesieur (Michele)

Intrasense Executives and Management Board

AL

Ms. Anne Larpin

Independent Director

Compensation9,000 EUR
PR

Mr. Patrice Rullier

Independent Director

Compensation9,000 EUR
FN

Mr. Francois Nicolas

Independent Chairman of the Board

AS

Mr. Alexandre Salvador

Chief Executive Officer

FV

Ms. Fanny Louvet - De Verchere

Chief Product & Marketing Officer

Frequently asked questions about Intrasense

The business model of Intrasense SA focuses on providing innovative medical imaging software solutions. Intrasense SA develops and commercializes advanced imaging software products, which enable healthcare professionals to optimize and streamline their diagnostic processes. By leveraging cutting-edge technologies, such as machine learning and artificial intelligence, Intrasense SA's software solutions improve the accuracy, efficiency, and decision-making capabilities in medical imaging, ultimately benefiting patients and healthcare providers. Intrasense SA's dedication to continuous research and development ensures that their software remains at the forefront of medical imaging technology, solidifying their position as a leader in the industry.

All fundamentals and in-depth analysis of Intrasense

Our stock analysis for Intrasense Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intrasense Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.